Long Term Follow-up of Pegylated-Interferon Alpha-2b

This study has been completed.

Sponsor:

Information provided by:

Foundation for Liver Research

ClinicalTrials.gov Identifier:

NCT00146705

First received: September 5, 2005

Last updated: July 31, 2007

Last verified: July 2007

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	September 2006
Estimated Primary Completion Date:	No date given

No publications provided by Foundation for Liver Research

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Buster EH, Flink HJ, Simsek H, Heathcote EJ, Sharmila S, Kitis GE, Gerken G, Buti M, de Vries RA, Verhey E, Hansen BE, Janssen HL. Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients. Am J Gastroenterol. 2009 Oct;104(10):2449-57. Epub 2009 Jul 7.

To Top